Healthcare Bankruptcies Slow After Peaking in 2023: Report
Athersys Finalizes Sale to HEALIOS Amidst Board Reorganization
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP
Acute Respiratory Distress Syndrome Treatment Market Size Is Set to Grow by USD 1.22 Bn From 2024-2028, Air Liquide SA, Athersys Inc. & Boston Scientific Corporation, and More to Emerge as Some of the Key Vendors, Technavio
Biotech Bankruptcies Hit a Record Despite Sector's Recovery
Healios Steps In as Primary Bidder and Lender for Athersys's Asset Sale Amidst Bankruptcy
Athersys to Sell Most Assets to Healios
Athersys Says It Entered Into Stalking Horse Asset Purchase Agreement With Healios K.K. >ATHX
Athersys, Units File Motion Seeking Approval of Certain Sale, Bid, Auction Procedures to Sell Substantially All Assets to Stalking Horse Bidder >ATHX
Athersys and Subsidiaries Filed for Relief Under Chapter 11 of U.S. Bankruptcy Code >ATHX
Athersys GAAP EPS of -$0.15
Athersys Q3 EPS $(0.15)
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
Athersys Files to Sell 76.25M Shares of Common Stock for Holders
Athersys Delisted From Nasdaq Risks Bankruptcy; Healios Remains Committed to Drug Development
Athersys to Extend Liquidity With Warrant Inducement, Global ARDS License
Athersys Gets Letter to Raise Up to $3.9M, Reiterates Bankruptcy Warning
Athersys Warrant Exercise Inducement Offer Letter To Raise Gross Proceeds Of Up To ~$3.9M From The Exercise Of 28,124,590 Warrants And Received The First Tranche Payment Of $1.5M From Healios K.K. Under The ARDS Global License
SciSparc SPRC Private Placement; Athersys ATHX Warrants
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
No Data
No Data